Pioglitazone improves whole‐body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome

AIMS/INTRODUCTION: Low aerobic capacity is a strong and independent predictor of all‐cause mortality in patients with metabolic syndrome (MetS). Here, we investigated the effects of pioglitazone treatment on whole‐body aerobic capacity and skeletal muscle energy metabolism in MetS patients. MATERIAL...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Diabetes Investig
मुख्य लेखकों: Yokota, Takashi, Kinugawa, Shintaro, Hirabayashi, Kagami, Suga, Tadashi, Takada, Shingo, Omokawa, Masashi, Kadoguchi, Tomoyasu, Takahashi, Masashige, Fukushima, Arata, Matsushima, Shouji, Yamato, Mayumi, Okita, Koichi, Tsutsui, Hiroyuki
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2017
विषय:
Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497029/
https://ncbi.nlm.nih.gov/pubmed/27930876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12606
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन